ifosfamide and nintedanib

ifosfamide has been researched along with nintedanib in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bovée, JVMG; Brahmi, M; Charon-Barra, C; Cousin, S; de Haan, J; De Meulemeester, L; Domènech, M; Dudzisz-Śledź, M; Estival, A; Gelderblom, H; Karavasilis, V; Litière, S; Marquina, G; Marreaud, S; Olungu, C; Schöffski, P; Steeghs, N; Toulmonde, M; Wozniak, A1

Trials

1 trial(s) available for ifosfamide and nintedanib

ArticleYear
Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-
    European journal of cancer (Oxford, England : 1990), 2021, Volume: 152

    Topics: Adult; Aged; Female; Humans; Ifosfamide; Indoles; Male; Medical Futility; Middle Aged; Neoplasm Staging; Progression-Free Survival; Prospective Studies; Response Evaluation Criteria in Solid Tumors; Sarcoma

2021